1. Rowbotham NJ, Smith S, Prayle AP, Robinson KA, Smyth AR. Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review. Thorax. 2018;74:229–36.
2. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, et al. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child. 1997;77(6):493–6.
3. Cystic Fibrosis Foundation. 2017 patient registry annual data report. Bethesda: Cystic Fibrosis Foundation; 2018.
https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf
.
4. James Lind Alliance. The James Lind Alliance Guidebook version 8. 2018 [updated November 2018]. Available from:
http://www.jla.nihr.ac.uk/jla-guidebook/
. Accessed 28 Jan 2019.
5. James Lind Alliance. Report of the JLA community workshop: 50 completed partnerships and beyond. 2017.Available from
http://www.jla.nihr.ac.uk/news-and-publications/downloads/Report%20of%20JLA%20Community%20Workshop%2050%20Completed%20Partnerships%20and%20Beyond_final.pdf
. Accessed 28 Jan 2019.